DrugPatentWatch Database Preview
Kaleo Inc Company Profile
What is the competitive landscape for KALEO INC, and what generic alternatives to KALEO INC drugs are available?
KALEO INC has three approved drugs.
There are twenty-nine US patents protecting KALEO INC drugs.
Summary for Kaleo Inc
| US Patents: | 29 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Kaleo Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | RX | Yes | Yes | 8,016,788 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | 9,474,869 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | 9,737,669 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-001 | Aug 10, 2012 | BX | RX | Yes | No | 8,226,610 | ➤ Sign Up | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Kaleo Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,899,987 | Simulated medicament delivery device having an electronic circuit system | ➤ Sign Up |
| 9,555,191 | Apparatus and methods for self-administration of vaccines and other medicaments | ➤ Sign Up |
| 9,814,838 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | ➤ Sign Up |
| 8,920,367 | Devices, systems and methods for medicament delivery | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Kaleo Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| United Kingdom | 201104754 | ➤ Sign Up |
| Japan | 5599500 | ➤ Sign Up |
| United Kingdom | 2477046 | ➤ Sign Up |
| United Kingdom | 201019599 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Kaleo Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 292 | Luxembourg | ➤ Sign Up | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
